Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.72B
Revenue (ttm)	193.90M
Net Income (ttm)	4.82M
Shares Out	2.40M
EPS (ttm)	2.01
PE Ratio	357.83
Forward PE	n/a
Dividend	1.00 (0.14%)
Ex-Dividend Date	Nov 23, 2025

Volume	26
Average Volume	668
Open	708.00
Previous Close	700.80
Day's Range	708.00 - 708.00
52-Week Range	675.00 - 947.90
Beta	-0.39
RSI	36.24
Earnings Date	Jan 21, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 474
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.